Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 18 hours agoSNK02 has the potential to be a first-in-class cryopreserved allogeneic NK cell therapy for solid tumors that does not require lymphodepletion before administration, which may lead to better ...
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance...
WTRF Wheeling· 3 days agoCelltrion USA announced today positive two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) for ZYMFENTRA™ (infliximab-dyyb) in adult patients with moderately to severely ...
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 3 days agoData from this study – the first Phase 3 treat-through data reported for an IL23p19 antibody – will be presented at Digestive Disease Week® (DDW), held in Washington, D.C.
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding
MedPage Today· 2 days agoAsthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 1 day agoUCB, a global biopharmaceutical company, today announced that The Lancet has published results from the Phase 3 BE HEARD I and BE HEARD II trials evaluating the efficacy and safety of BIMZELX ...
Dear Doctor: Man’s overactive bladder has him up 4, 5 times a night
OregonLive.com· 4 days agoROACH: I’m a 87-year-old male who was diagnosed with an overactive bladder. Nothing has worked; I’m up four to five times a night, which leaves me very tired the next day. ANSWER: Before making ...
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with...
Morningstar· 4 days agoPRINCETON, NJ / ACCESSWIRE / May 20, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoAustin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type (Non-Small Cell Lung Cancer, Metastatic Lung
Russell Investments Group Ltd. Lowers Stake in QuidelOrtho Co. (NASDAQ:QDEL)
ETF DAILY NEWS· 4 days agoRussell Investments Group Ltd. decreased its position in QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 40.8% during the fourth quarter, according to the company in its most recent disclosure ...
ALECT2 has a better prognosis than other types of amyloidosis
Arizona Daily Star· 4 days agoROACH: I recently saw a friend who had been diagnosed with ALECT2 amyloidosis, a form of chronic kidney disease that is not well-understood but is considered fatal. ALECT2 is the abnormal deposition of the protein leukocyte chemotactic factor 2.
